ai – Page 2 – Market Industry Forecast News

Industry 4.0 Market Addresses Challenges in Legacy Systems Integration

The global Industry 4.0 market size is expected to reach USD 627.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 19.9% from 2023 to 2030. The growth of the market is attributed to the widespread adoption of the Internet of Things (IoT) devices and sensors, facilitating seamless data integration, while the infusion of Artificial Intelligence (AI) and Machine Learning (ML) is propelling predictive analytics and autonomous operations. Furthermore, the rising consumer spending on digitalization and cutting-edge factory solutions will increase demand for Industry 4.0 solutions.

Industry 4.0 emphasizes the creation of interconnected ecosystems where devices, machines, and systems communicate and collaborate seamlessly. This trend leads to streamlined information flow, enabling real-time decision-making based on accurate and up-to-date data. Edge computing, which processes data closer to its source, and cloud integration are trends supporting this interconnection. The deployment of Industry 4.0 solutions optimizes resource utilization, energy consumption, and overall process efficiency. With real-time data collection and analysis, companies gain insights into operational bottlenecks, allowing for timely adjustments and continuous improvement. Trends, such as digital twins (virtual replicas of physical assets), enable simulation and optimization of processes, thereby enhancing efficiency.

Order a free sample PDF of the Industry 4.0 Market Intelligence Study, published by Grand View Research.

The transition to Industry 4.0 requires a workforce with the necessary skills to operate and maintain advanced technologies. However, there is often a shortage of workers with expertise in data analytics, robotics, and cybersecurity. Businesses may need to invest in training and upskilling programs to ensure that their workforce can effectively leverage Industry 4.0 technologies. Implementing Industry 4.0 technologies often requires a significant upfront investment. The costs associated with acquiring and deploying advanced machinery, sensors, data analytics systems, and connectivity infrastructure can be substantial. Small and medium-sized enterprises (SMEs) may face financial constraints in adopting these technologies, limiting their ability to compete with more prominent industry players.

In the evolving market, the robotics and automation trend encompasses several transformative elements, including collaborative robots designed for safe human interaction and the integration of intelligent Robotic Process Automation (RPA) that streamlines repetitive tasks and processes. Advanced sensing and perception capabilities enable robots to interact more effectively with their environment, bolstering accuracy and adaptability. Furthermore, the infusion of AI and ML empowers robots to learn, adapt, and make real-time decisions, augmenting their problem-solving ability.

The North America regional market growth is driven by the need to address labor shortages and rising operational costs. Automation and robotics were integrated into manufacturing processes to perform repetitive tasks, reducing the reliance on manual labor. This shift not only improved efficiency but also enhanced workplace safety. With improved cost-effectiveness, regional manufacturers were better positioned to compete globally. IoT played a pivotal role by connecting devices and machinery to the internet, enabling real-time data collection and analysis. This data-driven approach allowed companies to monitor equipment performance, predict maintenance needs, and optimize production processes. The insights from IoT-powered analytics enhanced decision-making reduced downtime, and minimized resource wastage.

Industry 4.0 Market Report Highlights

Industry 4.0 marks the next phase of manufacturing digitization, driven by disruptive trends like connectivity, data, human-machine interaction, analytics, and robotics. It also includes the enhancement of manufacturing efficiency through the integration of technology and automation into both production and managerial workflows
The demand for IoT is increasing in most sectors, and the role played by solution providers and vendors is further contributing to its extravagant growth. Numerous initiatives at the industry level have been promoting and advertising IoT applications and their use cases
Industry 4.0 thrives on data collection and analysis. With the proliferation of sensors and connected devices, companies gather vast amounts of data that can be leveraged for informed decision-making
The consistent advancement of additive manufacturing technologies has led to heightened capabilities in terms of precision, speed, and scalability. Innovations in materials, printing techniques, and post-processing methods have collectively contributed to making 3D printing a feasible and effective solution across industries

List of Key Players in the Industry 4.0 Market

ABB Ltd.
Cisco System Inc.
Cognex Corporation
Denso Corporation
Emerson Electric
Fanuc Corporation
General Electric Company
Honeywell International Inc.
Intel Corporation
Johnson Controls International
Kuka Group
Robert Bosch GmbH
Rockwell Automation Inc.
Schneider Electric SE
Siemens AG

Gather more insights about the market drivers, restrains and growth of the Global Industry 4.0 Market

Hospital Bed Management Systems Market Promotes Collaboration Across Departments

The global hospital bed management systems market size is expected to reach USD 3.8 billion by 2030, according to a new report by Grand View Research, Inc, expanding at a CAGR of 10.31% from 2023 to 2030. The key factors driving the market growth include the rising incidence of chronic and infectious diseases, increasing geriatric population, and growing adoption of real-time bed management in hospitals. Furthermore, increasing awareness of hospital supportive and friendly software for smooth functioning of bed allotment and rising number of hospitals and clinics are contributing to the market growth. As a result, the demand for growing need for hospital bed management systems is expected to rise in the near future.

Hospitals lose quality suffering and millions due to cancellations, diversions and delays around bed management. The key challenges faced by hospitals include poor coordination among caregivers, lack of data on bed status resulting in hidden beds, inefficient discharge procedures, and deprived forecasting on bed demand from hospital wards, intensive care units, and other specialized areas. Hospital bed management systems are designed to help healthcare organizations manage and maintain their hospital beds.

Order a free sample PDF of the Hospital Bed Management Systems Market Intelligence Study, published by Grand View Research.

The software offers a variety of features including optimized bed management, allocation, and tracking for effective hospital management. These features focus on improved patient care, boost overall efficiency, and enhance resource utilization. In addition, hospital bed management systems offer automated workflows, real-time communications, escalation notifications, and reduced patient wait times by coordination.

Furthermore, major players in the market are undertaking several strategic initiatives owing to the rising adoption of automation technologies. For instance, in March 2023, Masimo and Temple Health entered into collaboration with focus on hospital automation and telehealth initiatives to improve life, improve patient outcomes, and reduce the cost of care. Similarly, LeanTaaS completed the acquisition of intelligent automation solutions provider Hospital IQ developing an AI-powered hospital operations software provider valued at about USD 1 billion.

Moreover, growing government funding and initiatives are anticipated to boost market growth. As per the HIMSS Future of Healthcare Report, 80% of healthcare providers plan to boost investments in technology and digital solutions within the next five years. This initiative is projected to drive growth in various sectors, including hospital automation technologies including hospital bed management systems.

Hospital Bed Management Systems Market Report Highlights

Based on the type, the market is segmented into acute care beds, critical care bed and long-term care bed, and others.
The acute care bed segment is anticipated to dominate the global market in 2022 and expected to grow at a fastest CAGR of 10.68% during the forecast period. The growth is attributed to increasing acute care admission of patients for one to three days at the healthcare facilities.
On the basis of deployment mode, the web & cloud-based segment dominated the market with a maximum revenue share in 2022. The growth is attributed to the need to reduce maintenance expenses and ensure the smooth operation of medical equipment.
North America dominated the market with a revenue share of 40.9% in 2022. The growth of the region is driven by factors such as the increase in the increasing investments in healthcare infrastructure, rise in disposable income, and the thriving medical tourism industry in the region.
The Asia Pacific region is predicted to experience significant growth during the forecast period, owing to large patient pool, increased end-user awareness, and heavy government investment in digital transformation in the region.

List of Key Players of Hospital Bed Management Systems Market

Oracle
Epic Systems Corporation
GE Healthcare
Veradigm LLC
CentralSquare Technologies
Advanced Data Systems
Terawe Corp
Lyngsoe Systems A/S
The Access Group
EMIS Health
TeleTracking Technologies, Inc.
SAP

Gather more insights about the market drivers, restrains and growth of the Global Hospital Bed Management Systems Market

Supply Chain Analytics Market Challenges: Addressing Skills Gap in Data Analytics

The global supply chain analytics (SCA) market was estimated at USD 6.12 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 17.8% from 2023 to 2030. The increasing demand for SCA solutions is largely driven by heightened awareness of their benefits, which include improved forecasting accuracy, enhanced supply chain optimization, reduced waste, and the meaningful integration of business data. Additionally, the rising number of small and medium enterprises (SMEs) and their increased investment in analytics to strengthen their market positions and compete effectively are expected to further propel market growth over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Supply Chain Analytics Market

Segmentation Analysis:

Solution Insights

In terms of solutions, the sales and operations analytics segment held the largest market share, exceeding 28% in 2022. The need for optimizing resource utilization and reducing costs were key factors driving this segment’s growth. Clients benefit from flexible and customizable SCA solutions that can adapt to changing requirements while remaining cost-effective, contributing to the segment’s projected growth.

Logistics analytics solutions are essential for linking transportation networks with market demand forecasts and identifying product supply locations. The integration of big data within SCA enhances supply chain and logistics operations, effectively addressing customer needs and boosting satisfaction and loyalty. This trend is expected to drive growth in the logistics analytics segment over the forecast period.

The planning and procurement segment is also expected to experience significant growth, as demand forecasting in supply chain planning analytics encompasses factors like freight costs, production levels, distribution, and budgeting, which help users efficiently manage logistics operations.

Service Insights

Regarding services, the professional service segment accounted for over 60% of the market share in 2022. These services are crucial for ensuring that new systems integrate seamlessly with existing departmental systems, thereby minimizing data loss or theft. The growing demand for professional services focused on data analysis and protection, as well as expertise in emerging technologies, is contributing to this segment’s growth. However, the supply chain sector often lacks skilled professionals capable of identifying and analyzing trends that inform marketing decisions.

The support and maintenance segment is expected to register the fastest CAGR over the forecast period. Third-party support can lead to cost savings while providing access to skilled professionals. Addressing the technical complexities of software, maintaining and repairing systems, facilitating data transfers, and regularly updating software are all critical factors for the successful implementation of SCA solutions. Neglecting these areas could hinder productivity, making the demand for support and maintenance services crucial in the coming years.

Deployment Insights

In terms of deployment, the cloud segment dominated the market with over 62% share in 2022. The proliferation of technology has driven the widespread adoption of IoT devices, increasing the reliance of original equipment manufacturers (OEMs) on cloud-based platforms. Cloud deployment enhances flexibility and allows for extensive customization of products and services for organizations. The industry is particularly favoring big data analytics solutions for their advantages in data security and risk assessment. Improved mobility and user-friendliness of cloud services have further accelerated the adoption of supply chain analytics solutions on cloud platforms.

Additionally, the preference for cloud-based deployment is expected to grow, especially among enterprises in developing economies in the Middle East, Africa (MEA), and Asia Pacific, where a lack of in-house IT expertise often leads businesses to opt for cloud solutions. The increasing availability of cloud-based SCA options is expected to drive demand among small and medium enterprises due to benefits like easier deployment, shorter implementation timelines, better utilization of IT resources, and enhanced flexibility and mobility.

Enterprise Size Insights

In terms of enterprise size, large enterprises accounted for over 59% of the market share in 2022. The demand for robust monitoring solutions and automation capabilities for resource allocation and strategic decision-making fueled growth in this segment. Conversely, the small and medium enterprises segment is projected to grow at the fastest rate of 19.2% over the forecast period. This growth can be attributed to the increasing number of SMEs in developing countries such as Mexico and India, along with their need for internal network architectures for data storage.

The rising adoption of IT infrastructure among SMEs to enable digital services across various business channels is expected to contribute to the growth of this segment. Additionally, government initiatives aimed at promoting digital campaigns for SMEs globally are likely to further stimulate growth.

End-use Insights

In terms of end-use, the manufacturing segment held the largest market share at over 23% in 2022. SCA solutions in manufacturing can enhance performance by providing real-time data access across the value chain and reflecting updates across various processes within the organization. The growing demand for products and the necessity to ensure their availability and timely delivery are driving the need for improved supply chain efficiency. For instance, in April 2023, Snowflake, a data cloud company, launched the Manufacturing Data Cloud, designed for the automotive, technology, and industrial sectors. This platform allows manufacturers to collaborate effectively with suppliers, partners, and customers, ultimately improving supply chain performance and supporting smart manufacturing initiatives.

The Manufacturing Data Cloud equips manufacturers with tools to work collaboratively and securely with their partners, suppliers, and customers, enhancing agility and visibility throughout the value chain. In today’s digital industrial landscape, businesses can leverage this platform to strengthen supply chain performance, implement smart manufacturing projects, and establish a solid data foundation for their operations.

As e-commerce continues to expand and businesses strive to provide seamless delivery experiences, efficient supply chain planning has become increasingly critical. The rapid growth of the e-commerce sector, combined with the integration of big data and artificial intelligence into SCA, is anticipated to be a key driver of global demand for effective supply networks, particularly benefitting the retail and consumer goods segments during the forecast period.

Order a free sample PDF of the Supply Chain Analytics Market Intelligence Study, published by Grand View Research.

Patient Engagement Solutions Market Challenges: Addressing User Adoption and Trust Issues

The global patient engagement solutions market was valued at approximately USD 22.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.7% from 2024 to 2030. Key drivers for this growth include ongoing technological advancements, the increasing adoption of Electronic Health Records (EHR) and mobile health (mHealth) solutions, the rising prevalence of chronic diseases, supportive initiatives from major stakeholders, and a growing consumer focus on healthcare. A survey conducted by NextGen Healthcare in 2021 revealed that 83% of ambulatory healthcare providers believe that patient engagement solutions are essential for achieving both financial success and improved patient outcomes, with the COVID-19 pandemic further accelerating market growth.

Gather more insights about the market drivers, restrains and growth of the Global Patient Engagement Solutions Market

Segmentation Analysis:

Delivery Type Insights

In 2023, the web and cloud-based segment dominated the market, holding a substantial 78.0% revenue share, and is projected to experience the fastest growth throughout the forecast period. The increasing adoption of these solutions is attributed to their ability to provide remote access to real-time data tracking, integrated features, easy accessibility, low handling costs, and straightforward data backup. Consequently, companies are increasingly investing in web and cloud-based patient engagement solutions. For instance, Microsoft introduced Microsoft Cloud for Healthcare in May 2020, aiming to enhance patient engagement and facilitate collaboration among healthcare teams through telehealth and data analytics capabilities.

On-premise services also play a crucial role, offering secure patient data management and ease of access, driven by the desire for comprehensive information access within healthcare facilities.

Component Insights

The software and hardware segment accounted for the largest revenue share of 62.7% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. These components form the core offerings of patient engagement solutions, providing intuitive user interfaces and continuous product upgrades that simplify installation, usage, and record retrieval. An example is FollowMyHealth from Allscripts, a widely used mobile-first, customizable patient engagement solution that enhances care quality and patient satisfaction.

The services segment is essential for the effective operation of patient engagement solutions, aiding in their optimization based on customer needs and maximizing health outcomes. This segment encompasses consulting, implementation, training, support and maintenance, as well as services related to interoperability and access to EHR data.

Functionality Insights

In 2023, the communication segment held the largest revenue share at 35.0%, forming the foundational offering of any patient engagement solution. This dominance is driven by the growing demand for telehealth, mHealth, and various virtual communication channels, including audio, video, and text. The pandemic accelerated the adoption of these virtual communication solutions, extending their applications to remote patient monitoring and mental health services.

The health tracking and insights segment is projected to grow at the fastest rate of 19.1% over the forecast period, fueled by the increasing integration of data analytics, artificial intelligence (AI), and machine learning to provide actionable insights for patients and their healthcare providers. For instance, Nuance Communications, Inc. introduced Nuance Mix, a conversational AI platform utilizing deep learning-based speech and natural language understanding technologies. In September 2021, Leidos partnered with Nuance to incorporate this platform and its omnichannel development tools into custom patient engagement solutions.

End-use Insights

The providers segment captured the largest revenue share, exceeding 47.0% in 2023. Providers, who cater to the highest volume of patients and serve as the primary point of contact for health consultations, are the leading adopters of patient engagement solutions. For example, in December 2021, Northwell Health in the U.S. implemented a patient engagement platform by Playback Health at select clinical sites, promoting mobility and secure sharing of point-of-care medical data.

Conversely, the payers segment is expected to grow at the fastest rate of 18.0% during the forecast period. The expansion of this segment is attributed to the increasing adoption of patient and customer engagement solutions that enable broad coverage and support value-based care delivery. Payers are focusing on managing patient care and ensuring connectivity at every stage of the treatment process.

Therapeutic Area Insights

Chronic disease management dominated the market in 2023, holding a revenue share of over 44.7%. The growing geriatric population in key markets, along with the rising prevalence of chronic diseases and accelerated adoption of digital technologies driven by the COVID-19 pandemic, have significantly contributed to the segment’s large share. Patient engagement solutions facilitate chronic disease management by enabling prevention and detection of conditions and supporting both provider-led and self-management strategies.

The health and wellness segment is projected to experience the fastest growth rate of 18.0% over the forecast period, driven by initiatives from leading companies, an expansion of product offerings covering mental health, weight management, and pregnancy, as well as increased research activities. For instance, in June 2023, Cardinal Health finalized an agreement to transfer its Outcomes business to Transaction Data Systems, enhancing patient engagement and clinical pharmacy solutions, thereby strengthening connections between payers and pharmaceutical companies within its extensive pharmacy network.

Application Insights

Outpatient health management accounted for over 39.0% of the market share in 2023, highlighting its dominance. The segment encompassing research and development (R&D) and preventive care is expected to grow at the fastest rate of 18.0% throughout the forecast period. Patients with chronic conditions require continuous monitoring and updates regarding their health management. The rise of healthcare consumerism has also led patients to become more engaged in care planning, tracking, and optimization.

Patient engagement solutions enable remote connections between patients and their healthcare providers, facilitating the efficient exchange of information, patient feedback, and other health-related data. For example, in November 2019, the CDC funded 13 state-level arthritis management and prevention programs to enhance the quality of life and monitoring for rural arthritis patients. Additionally, the adoption of patient engagement solutions for R&D purposes by medical device manufacturers, pharmaceutical companies, and other life sciences entities is expected to grow significantly due to increasing product availability and demand.

Order a free sample PDF of the Patient Engagement Solutions Market Intelligence Study, published by Grand View Research.

Embolic Protection Devices Market Report: Regulatory Changes Impacting Industry Growth

The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Access the Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 – 2030

Embolic Protection Devices Market Report Highlights

Distal filter devices segment emerged as the largest segment owing to high demand for these devices

Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders

North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period

Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region

The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Key Embolic Protection Devices Company Insights

Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry.

Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.

Order your free sample copy of “Embolic Protection Devices Market Report 2024 – 2030, published by Grand View Research

Key Embolic Protection Devices Companies:

The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.

Boston Scientific Corporation
Edwards Lifesciences Corporation.
Abbott.
Medtronic
Cardinal Health.
Innovative Cardiovascular Solutions, LLC
Transverse Medical, Inc.
W. L. Gore & Associates, Inc.

Recent Developments

In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR).

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Enterprise Content Management Market Challenges: Navigating Compliance and Security Risks

The global enterprise content management market size is expected to reach USD 102.01 billion by 2030, according to a study conducted by Grand View Research, Inc., registering a CAGR of 15.1% from 2024 to 2030. Soaring need for securing confidential data is triggering the adoption of enterprise content management (ECM) software. Components of the software include solutions and services such as document management, web content management, records management, document collaboration, and digital rights management. These solutions enable enterprises to reduce their data storage costs and enhance productivity by allowing them to collaborate with employees.

In North America, availability of advanced IT infrastructure and presence of prominent IT giants such as IBM and Microsoft Corporation is poised to drive the adoption of enterprise content management software. Latin American and MEA are projected to witness considerable growth over the coming years owing to growing preference of enterprises for cloud and rising need for IT services by the government sector.

However, vendor dependence and high cost of maintenance are likely to hamper the growth of the market. To overcome this, ECM providers may offer flexibility to enterprises and low-cost maintenance services for gaining credence among organizations.

Access the Enterprise Content Management Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment (Cloud And On-Premise), By Enterprise Size, By Application, By Region, And Segment Forecasts, 2024 – 2030

Enterprise Content Management Market Report Highlights

The services segment is expected to post the highest CAGR of over 17.0% during the forecast period due to growing emphasis on periodic maintenance and employee training to enhance operational efficiencies

Cloud-based ECM provides benefits such as high service level, which will drive the growth of the segment over the forecast period. The segment is anticipated to command more than 55.6% % of the overall market revenue by 2030.

The North America enterprise content management market accounted for the largest market revenue share of 41.1% in 2023

Key Enterprise Content Management Company Insights

Some of the key companies in the enterprise content management market include Microsoft Corporation, IBM Corporation, OpenText Corporation, Hyland Software, Inc., Alfresco Software, Inc., and M-Files Corporation. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

Microsoft Corporation provides a comprehensive suite of ECM solutions catering to modern businesses’ diverse needs. From document management to collaboration tools to data protection, Microsoft’s offerings empower organizations to manage their digital content while ensuring security and compliance efficiently.

IBM Corporation provides a full range of Enterprise Content Management (ECM) solutions through IBM FileNet. FileNet offers a centralized place to securely store and organize all your business data, such as documents, emails, images, and more.

Order your free sample copy of “Enterprise Content Management Market Report 2024 – 2030, published by Grand View Research

Key Enterprise Content Management Companies:

The following are the leading companies in the enterprise content management market. These companies collectively hold the largest market share and dictate industry trends.

Microsoft Corporation
IBM Corporation
OpenText Corporation
Hyland Software, Inc.
Alfresco Software, Inc.
M-Files Corporation
Oracle Corporation
Box, Inc.
Laserfiche
DocuWare Corporation

Recent Developments

In January 2024, Microsoft announced the expansion of its Copilot feature, aiming to bring its full power to more people and businesses. This move signifies Microsoft’s commitment to enhancing productivity and collaboration through innovative AI technologies.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

Therapeutic Drug Monitoring Market Challenges: Overcoming Data Management Issues

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Access the Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 – 2030

Therapeutic Drug Monitoring Market Report Highlights

The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.

The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.

The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.

The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Key Therapeutic Drug Monitoring Company Insights

Some of the key companies in the therapeutic drug monitoring market are Abbott, ALPCO, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Chromsystems Instruments & Chemicals GmbH, F.Hoffmann-La Roche Ltd., Randox laboratories Ltd, Siemens Healthineers AG., and biomérieux, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.

Abbott, known for its diagnostic technologies, offers a range of products and solutions tailored to monitor drug levels in patients effectively. These include assays and instruments that aid healthcare providers in optimizing medication dosages, ensuring efficacy, and enhancing patient safety across various therapeutic areas.

ALPCO (American Laboratory Products Company) is a player in the therapeutic drug monitoring market, specializing in providing high-quality assays and immunoassay kits. These products are designed to accurately measure drug levels in patient samples, supporting healthcare providers in optimizing therapeutic outcomes and patient management.

Order your free sample copy of “Therapeutic Drug Monitoring Market Report 2024 – 2030, published by Grand View Research

Key Therapeutic Drug Monitoring Companies:

The following are the leading companies in the therapeutic drug monitoring market. These companies collectively hold the largest market share and dictate industry trends.

Abbott
ALPCO
Beckman Coulter, Inc
Bio-Rad Laboratories, Inc
Thermo Fisher Scientific Inc.
Chromsystems Instruments & Chemicals GmbH
F.Hoffmann-La Roche Ltd.
Randox laboratories Ltd
Siemens Healthineers AG.
biomérieux, Inc.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Soup Market Challenges: Addressing Supply Chain Issues and Quality Concerns

The global soup market size is expected to reach USD 26.21 billion by 2030, registering a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing demand for processed, ready to eat, and packed food and increasing women workforce are expected to increase the market demand in the upcoming years. In addition, increase in disposable income and changing consumer lifestyle in emerging economies including China and India are anticipated to increase the demand for soups.

Consumption of canned and dried soup products is increasing in North America and Europe, on account of continuous product innovation as per customer behavior and preferences. In addition, growing economic independence among women is increasing the consumption of packed and processed food products in the developed countries.

Access the Soup Market Size, Share & Trends Analysis Report By Product (Canned, Dried, UTH), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Online), By Region And Segment Forecasts, 2024 – 2030

Soup being a healthy source of vitamins, minerals, nutrition, and protein serves as a prominent replacement for home cooked food. Therefore, this evolution in the working population is anticipated to significantly influence the demand for soup in future. Demand for soups in restaurants, food outlets, and food joints is expected to acquire a small market share due to growing consumer preference for ready to eat products and rising inclination towards healthy food habits.

Continuous use of cornstarch and salt in canned and dried soup products is expected to act as a restraining factor in the global market. High consumption of corn starch can lead to several health issues like increased level of blood sugar and blood pressure. However, continuous product development by companies such as Campbell Soup Company, which provides new flavors like roasted red pepper and tomato, butternut squash and sweet potato, and harvest carrot and ginger, is expected to influence the buying behavior of the younger population across the globe. The market leaders are focusing on developing new flavors and products in order to make their style statement in the market.

Soup Market Report Highlights

By product, The UHT (ultra-high temperature) segment is expected to register the fastest CAGR during the forecast period. The growth of UHT soups is driven by long-shelf-life ingredients that don’t require refrigeration, making them ideal for busy lifestyles and reducing meal waste.

The dried segment accounted for the largest market revenue share of 59.5% in 2023. The Growing demand for convenient and prepared-to-eat food alternatives, specifically in busy city populations, offers a significant opportunity for producers to innovate and expand their product services.

The supermarkets/hypermarkets segment dominated the market in 2023. Supermarkets/hypermarkets offer various soup varieties from different brands and nutritional needs, providing consumers with vast choices and convenient shopping in the same place.

The Europe region dominated the market with a revenue share of 38.9% in 2023. The climate in Europe also plays a role in the growth of the soup market.

Order your free sample copy of “Soup Market Report 2024 – 2030, published by Grand View Research

Key Soup Company Insights

The Soup Market is witnessing substantial growth in the coming years, driven by way of numerous key techniques and factors. Market players are increasingly focusing on product innovation and development to fulfill evolving customer needs and options.

The Campbell Soup Company offers a variety of products, including canned soups, stocks, broths, and sauces. Its product lineup also features snacks such as Goldfish crackers and Milano cookies, beverages such as V8 juices, and pasta sauces under the Prego brand.

Nestle is food & beverage company which operates in various segments including baby food, bottled water coffee, dairy products, and others. The brand also includes Nescafe, KitKat, and Purina. Nestle emphasizes nutrition, health, and wellness in its product offerings.

Key Soup Companies:

The following are the leading companies in the soup market. These companies collectively hold the largest market share and dictate industry trends.

Associated British Foods plc
Baxters Food Group Limited
Campbell Soup Company
Conagra Brands, Inc.
General Mills, Inc.
Hindustan Unilever Limited
Nestlé S.A
Ottogi Co., Ltd
Premier Foods Group Limited
The Kraft Heinz Company

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Sheet Molding and Bulk Molding Compound Market: Addressing Challenges in Supply Chain Management

The global sheet molding and bulk compound market size is expected to reach USD 5.90 billion by 2030, registering a CAGR of 6.39% from 2024 to 2030, according to a new report by Grand View Research, Inc.
Sheet molding compound (SMC) is widely used in transportation applications because of its excellent mechanics and lightweight nature. They have electrical insulation and are resistant to fire, corrosion, and stains. Traditional materials such as steel, iron, and aluminum are being supplanted by SMC and BMC due to their distinct perceived benefits. Automobile makers are probably going to rely less on steel and more on sheet molding compound (SMC) as the market for lightweight materials and solid compounds grows.

The report “Sheet Molding And Bulk Molding Compound Market Size, Share & Trends Analysis Report By Resin Type (Epoxy, Polyester), By Fiber Type (Glass Fiber, Carbon Fiber), By Application, By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

In addition to the intrinsic limits of metals and their rising costs, a number of firms are substituting metal for thermoset composites in high-performance applications. This is helping to drive the expansion of the sheet molding compound (SMC) market. Many firms now favor lightweight materials because of the direct correlation between fuel usage and the weight of the materials used in manufacturing.
The market offers a lot of room for expansion and innovation, especially in the area of environmentally friendly and sustainable composites development. Global attention to sustainability and minimizing environmental effect has led to an increase in demand for recyclable or renewable materials. Producers are allocating resources to R&D in order to develop recyclable composites and bio-based resins that preserve the performance attributes of conventional SMC and BMC. Moreover, the growing utilization of these materials in developing sectors including infrastructure construction and renewable energy presents fresh opportunities for market participants to flourish.

Sheet Molding And Bulk Molding Compound Market Report Highlights:
Based on fiber type, glass fiber held the market with the largest revenue share of 63.07% in 2023. Glass fiber is the most commonly used reinforcement material in SMC and BMC due to its excellent mechanical properties, cost-effectiveness, and versatility
Based on application, automotive & transportation held the market with the largest revenue share of 31.23% in 2023. The automotive & transportation sector is a major driver of market growth, as SMC and BMC materials are increasingly used for manufacturing lightweight and high-strength components, such as body panels, bumpers, and structural parts
North America holds a substantial share of the market, driven by robust demand from the automotive and aerospace industries. The U.S., in particular, is a major contributor, with its strong manufacturing base and technological innovation
Order your free sample copy of “Sheet Molding And Bulk Molding Compound Market Report 2024 – 2030, published by Grand View Research

Sheet Molding And Bulk Molding Compound Market Segmentation
Grand View Research has segmented the global sheet molding and bulk molding compound market based on resin type, fiber type, application, and region:
Sheet Molding And Bulk Molding Compound Resin Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Epoxy
Polyester
Sheet Molding And Bulk Molding Compound Fiber Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Glass Fiber
Carbon Fiber
Sheet Molding And Bulk Molding Compound Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Automotive & Transportation
Aerospace
Electrical & Electronics
Building & Construction
Domestic Appliances
Others
Sheet Molding And Bulk Molding Compound Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
South Korea
Central & South America
Brazil
Argentina
MEA
South Africa
Saudi Arabia

List of Key Players in the Sheet Molding And Bulk Molding Compound Market
IDI Composites International
National Composites
MENZOLIT
Polynt (Polynt-Reichhold)
Continental Structural Plastics Inc. (TEIJIN)
ZOLTEK (Toray Group)
Mitsui Chemicals
TORAY INTERNATIONAL
Core Molding Technologies
Devi Polymers Private Limited
Zhejiang Yueqing SMC & BMC Manufacture Factory
Huayuan Advanced Materials Co., Ltd.
Resonac Holdings Corporation

About Grand View Research:
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Hydrogel-based Drug Delivery System Market Key Insights: Navigating Emerging Trends

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Access the Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 – 2030

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023

The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology

The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength

Based on delivery route, the ocular segment accounted for the largest revenue share in 2023

The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out

North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems

In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Order your free sample copy of “Hydrogel-based Drug Delivery System Market Report 2024 – 2030, published by Grand View Research

Key Hydrogel-based Drug Based Delivery System Company Insights

Some key companies in the market include GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch + Lomb; Medtronic; and Ocular Therapeutix, Inc. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other emerging and prominent industry participants.

Ocular Therapeutix, Inc., is a biopharmaceutical company that specializes in creating, advancing, and marketing new treatments for eye disorders. It employs its own bioresorbable hydrogel-based formulation technology, ELUTYX. The company has manufacturing facilities in Massachusetts.

Blairex Laboratories, Inc., a global pharmaceutical company, delivers products related to the consumer and pharmaceutical industry. Some of the company’s major offerings are sterile saline solutions and contact lens care.

Key Hydrogel-based Drug Delivery System Companies:

The following are the leading companies in the hydrogel-based drug delivery system market. These companies collectively hold the largest market share and dictate industry trends.

GALDERMA
Blairex Laboratories, Inc
Johnson & Johnson
Bausch + Lomb.
Medtronic
Ocular Therapeutix, Inc.
Ferring B.V.
Endo, Inc.
Tolmar Inc

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com